Navigation Links
European Society for Medical Oncology (ESMO) Presents Data from the,Clinical Trial of MediGene's Cancer-Killing Virus in Press,Conference

* Presentation of efficacy trends from ongoing phase I/II trial of oncolytic HSV * Poster selected by ESMO for presentation in press conference

MARTINSRIED, Germany, June 29, 2007.--The biotech company MediGene AG (Frankfurt, Prime Standard: MDG) announces that a case report from the ongoing clinical trial of MediGene's cancer killing virus will be presented in a press conference held by the European Society for Medical Oncology. Out of more than 300 posters accepted for the conference, only five were chosen for presentation in the press conference.

The event will take place on Friday, July 6, at 12:30 MEST at the ESMO conference in Lugano, Switzerland (ECLU). Dr. Axel Mescheder, Head of Clinical Research and Development at MediGene, will present the data in the press conference as well as in a poster presentation during the conference.

The phase I/II trial of NV1020 for the treatment of liver metastases of colorectal cancer is being conducted at seven leading cancer centers in the US. In September 2006, MediGene announced positive safety and efficacy data from an interim analysis of this study. The poster presented at the ESMO conference shows efficacy data in a case study for the first time.

Dr. Ulrich Delvos, Chief Operating Officer of MediGene, comments. "We are delighted and proud that the European Society for Medical Oncology has decided to present a case study from our trial in a press conference. Considering the number of studies presented on Europe's largest cancer congress, this emphasizes the innovation and the potential of this approach to fight cancer."

Journalists interested in joining the press conference please contact media@esmo.org

This press release contains forward-looking statements that involve risks and uncertainties. The forward-looking statements contained herein represent the judgmen
'"/>




Page: 1 2

Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
5. Malvern initiates European user group meetings for chemical imaging
6. PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference
7. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
8. Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology
9. Inspire Announces Presentations at Two European Scientific Conferences
10. Sunesis Pharmaceuticals Reports Positive Data From Studies of Two Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of the European Hematology Association
11. Archimedes Pharma Presents Positive Efficacy and Safety Data on Nasalfent at European Association for Palliative Care Congress

Post Your Comments:
(Date:11/20/2009)...stCall/ -- Medco Health Solutions, Inc (NYSE: MH...merican healthcare through an advanced, wired phar...ality clinical care and fundamentally bending the ... the benefit of patients and payors alike. ,, T... strategy enable "Smarter Medicine" to help addres...
(Date:11/20/2009).../ -- Reportlinker.com announces that a new market ..., Pipettes & Pipettors - A Global Market Per...4373/Pipettes--Pipettors---A-Global-Market-Perspec...amp;utm_campaign=prnewswire ,, Pipettes and p...search laboratory. Large-scale applications in lif...
(Date:11/20/2009).../ -- Reportlinker.com announces that a new market ..., Medical Adhesives and Sealants - A US Market R...2/Medical-Adhesives-and-Sealants---A-US-Market-Rev...mp;utm_campaign=prnewswire ,, The use of medi...in medical devices and equipments. Cutting edge me...
Breaking Medicine Technology:Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 2Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 3Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 4Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6MoviMED Announces Participation in NIWeek 2009 Conference to Examine Trends and Technologies for Boosting Productivity and Increasing Competitive Adva 52876 1MoviMED Announces Participation in NIWeek 2009 Conference to Examine Trends and Technologies for Boosting Productivity and Increasing Competitive Adva 52876 2MoviMED Announces Participation in NIWeek 2009 Conference to Examine Trends and Technologies for Boosting Productivity and Increasing Competitive Adva 52876 3Students Connect with Stable Careers Through Updated Medical Assistant Career Resources on All Allied Health Schools 52873 1Students Connect with Stable Careers Through Updated Medical Assistant Career Resources on All Allied Health Schools 52873 2Students Connect with Stable Careers Through Updated Medical Assistant Career Resources on All Allied Health Schools 52873 3Financing Available for Healthcare Equipment from DRE Medical Equipment 52870 1Financing Available for Healthcare Equipment from DRE Medical Equipment 52870 2Financing Available for Healthcare Equipment from DRE Medical Equipment 52870 3
...upport Phase III Study, DEERFIELD, Ill., Aug. 28 ...lzheimer,s Disease Cooperative Study (ADCS) group,...ter U.S. Phase III study,evaluating the role of Ga...)] (IGIV), an intravenous immunoglobulin preparati...erate alzheimer,s disease. GAMMAGARD,Liquid contai...
...(Nasdaq: CRGN ) and TopoTarget A/S (Copenhagen St... of patient dosing in a Phase I/II clinical,trial ...ase (HDAC),inhibitor, in combination with the anth...eloid Leukemia (AML). The trial is being conducted...s under the age of 60 with relapsed or refractory ...
Other Medicine Technology:Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 2Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 3Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 4Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 5Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease 6CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia 2CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia 3CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia 4CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia 5CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia 6
(Date:11/20/2009)...umers save up to one-third buying 90-day supply, s...y News) -- Buying a three-month supply of prescrip...a one-month supply, according to a new study. ,...lled for 395 drugs between 2000 and 2005, and foun...stead of a one-month supply saved an average 29 pe...
(Date:11/20/2009)... , Project Bread addresses increased food ...OSTON, Nov. 20 Project ...n, released numbers from its upcoming annual statu...eting trends described in this report, caused by h...ommonwealth struggling with hunger. Food insecurit...
(Date:11/20/2009)... , BATON ROUGE, La., Nov. 20 /PRNewswire-USN...Plans (LAHP) today warned that Louisianians could ... benefits if proposals being considered by Congres... chief executive officer for LAHP, "Louisiana heal...reform since the beginning of the national debate....
(Date:11/20/2009)... , MARINA DEL REY, Calif., Nov. 20 /PRNewswire/...O and President Dr. Richard Merkin, announce that ...Inc., as well as all its affiliated entities, have...art of the HPN family. ,, "We first and foremos...e in the HPN family are dedicated to maintaining t...
(Date:11/20/2009)... , NEW YORK, Nov. 20 Repo...report is available in its catalogue. ,, Oncol...Forecast to 2013 ,, http://www.reportlinker....marks-and-Market-Forecast-to-2013.html#utm_source=...wswire ,, Comprehensive Forecasts and Detaile...
Breaking Medicine News(10 mins):Health News:Three-Month Supply Lowers Drug Costs 2Health News:554,000 in Massachusetts Struggle to Put Food on the Table 2Health News:554,000 in Massachusetts Struggle to Put Food on the Table 3Health News:554,000 in Massachusetts Struggle to Put Food on the Table 4Health News:Congressional Health Care Reform Proposals Would Make Health Care More Expensive, Reduce Benefits for Louisianians 2Health News:Heritage Provider Network CEO Dr. Richard Merkin, Announces the Acquisition of Lakeside Medical Systems, Inc. 2Health News:Heritage Provider Network CEO Dr. Richard Merkin, Announces the Acquisition of Lakeside Medical Systems, Inc. 3Health News:Reportlinker Adds Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013 2Health News:Reportlinker Adds Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013 3
... Recovery for Many Facing Health Crises , , CHICA...s of patients facing health challenges have found ...such as CarePages.com believe it does. To them,... Just ask Lisa, who was diagnosed with Stage IV no...
... Lark, MD, noted medical researcher and women,s he...ing a battle against the Food and Drug Administrat...tical hormones. , Potomac...le against the Food and Drug Administration,s (FDA...
...rn is mounting for thousands of hip replacement pa...ecall . The Cleveland Law Firm of Spangenberg Shib...these types of cases on their website SpangLaw.com...ponent to grow, as more patients experience failur...
... January 15 Essilor,International announced today...signed a share purchase agreement whereby it has o...orlite, a manufacturer of ophthalmic lenses. The,a... The acquisition is expected to be completed in th...
... Smith & Nephew,s Advanced Wound Management di...uesday, the Specialist Patents Court in the High C...ic Concepts, Inc (NYSE: KCI ) a temporary injunc...njunction will remain in place until the court can...
... BD (Becton, Dickinson and Company) (NYSE: BDX )...oday that it will host a live webcast of its Annua...2009, at 1 p.m. (ET). , , The webcast can be acce... global medical technology company that develops, ...
Other Medicine News:Health News:More than Just a Box of Chocolates 2Health News:More than Just a Box of Chocolates 3Health News:Susan Lark, MD Continues to Urge Women to Fight for Their Right to Use Bioidentical Hormones 2Health News:Susan Lark, MD Continues to Urge Women to Fight for Their Right to Use Bioidentical Hormones 3Health News:Hip Replacement Patients at Possible Risk, Cleveland Law Firm Adds Zimmer Durom Cup Lawsuit Info on SpangLaw.com 2Health News:Hip Replacement Patients at Possible Risk, Cleveland Law Firm Adds Zimmer Durom Cup Lawsuit Info on SpangLaw.com 3Health News:Hip Replacement Patients at Possible Risk, Cleveland Law Firm Adds Zimmer Durom Cup Lawsuit Info on SpangLaw.com 4Health News:Essilor Agrees to Acquire Signet Armorlite 2Health News:Smith & Nephew Advanced Wound Management Comments on Temporary Injunction in United Kingdom 2Health News:Smith & Nephew Advanced Wound Management Comments on Temporary Injunction in United Kingdom 3
Amsler Manual
VIKING Coronary Guide Catheter
...em is designed to provide easy and accurate stent ...osis and are at high risk for conventional surgery...otid Stent System is 6F sheath/8F guide catheter c...CULINK utilizes rapid exchange (RX) technology so ...
Cryomatic Cryosurgical System
Medicine Products: